Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Molecular Cancer Therapeutics
|
November 6, 2009
MUC1 oncoprotein is a druggable target in human prostate cancer cells
Maya Datt Joshi, Rehan Ahmad, Li Yin, et al.
Molecular Cancer Research : MCR
|
September 24, 2016
MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway
Maroof Alam, Audrey Bouillez, Ashujit Tagde, et al.
Oncotarget
|
October 21, 2017
Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma
Ashujit Tagde, Tahireh Markert, Hasan Rajabi, et al.
ARYA Atherosclerosis
|
June 26, 2014
Stent underexpansion in angiographic guided percutaneous coronary intervention, despite adjunctive balloon post-dilatation, in drug eluting stent era
Mehrdad Taherioun, Mohammad Hassan Namazi, Morteza Safi, et al.
Science Signaling
|
February 18, 2011
MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop
Rehan Ahmad, Hasan Rajabi, Michio Kosugi, et al.
Oncoimmunology
|
September 22, 2017
MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer
Audrey Bouillez, Dennis Adeegbe, Caining Jin, et al.
Cancer Research
|
February 3, 2016
Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
Audrey Bouillez, Hasan Rajabi, Sean Pitroda, et al.
Molecular and Cellular Biochemistry
|
July 9, 2024
Insight into the cardioprotective effects of melatonin: shining a spotlight on intercellular Sirt signaling communication
Alireza Yaghoobi, Malihe Rezaee, Neda Hedayati, et al.
Oncotarget
|
June 4, 2016
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
Ashujit Tagde, Hasan Rajabi, Dina Stroopinsky, et al.
Scientific Reports
|
August 9, 2017
MUC1-C activates EZH2 expression and function in human cancer cells
Hasan Rajabi, Masayuki Hiraki, Ashujit Tagde, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Molecular Cancer Therapeutics
|
November 6, 2009
MUC1 oncoprotein is a druggable target in human prostate cancer cells
Maya Datt Joshi, Rehan Ahmad, Li Yin, et al.
Molecular Cancer Research : MCR
|
September 24, 2016
MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway
Maroof Alam, Audrey Bouillez, Ashujit Tagde, et al.
Oncotarget
|
October 21, 2017
Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma
Ashujit Tagde, Tahireh Markert, Hasan Rajabi, et al.
ARYA Atherosclerosis
|
June 26, 2014
Stent underexpansion in angiographic guided percutaneous coronary intervention, despite adjunctive balloon post-dilatation, in drug eluting stent era
Mehrdad Taherioun, Mohammad Hassan Namazi, Morteza Safi, et al.
Science Signaling
|
February 18, 2011
MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop
Rehan Ahmad, Hasan Rajabi, Michio Kosugi, et al.
Oncoimmunology
|
September 22, 2017
MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer
Audrey Bouillez, Dennis Adeegbe, Caining Jin, et al.
Cancer Research
|
February 3, 2016
Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
Audrey Bouillez, Hasan Rajabi, Sean Pitroda, et al.
Molecular and Cellular Biochemistry
|
July 9, 2024
Insight into the cardioprotective effects of melatonin: shining a spotlight on intercellular Sirt signaling communication
Alireza Yaghoobi, Malihe Rezaee, Neda Hedayati, et al.
Oncotarget
|
June 4, 2016
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
Ashujit Tagde, Hasan Rajabi, Dina Stroopinsky, et al.
Scientific Reports
|
August 9, 2017
MUC1-C activates EZH2 expression and function in human cancer cells
Hasan Rajabi, Masayuki Hiraki, Ashujit Tagde, et al.
Page
of 6